|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Keratoconus | |||||
| 2 | More general conditions related to this trial | ||||
| Corneal Diseases | |||||
| Eye Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| corneal cross-linking (CCL) | |||||
| Riboflavin/dextran eyedrops | |||||
| UV-X system | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Riboflavin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Dermatologic Agents | |||||
| Growth Substances | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Photosensitizing Agents | |||||
| Physiological Effects of Drugs | |||||
| Radiation-Sensitizing Agents | |||||
| Therapeutic Uses | |||||
| Vitamin B Complex | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| Ullevaal University Hospital | |||||